Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), to Present Data on LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye, at the American Society of Cataract and Refractive Surgery Annual Meeting
BERWYN, Pa.--(BUSINESS WIRE)--Nordic Pharma, Inc. will be presenting data on LACRIFILL® Canalicular Gel during the ASCRS Annual Meeting in Boston, MA on April 5-8, 2024.